極氪(ZK.US)首日上市一度大升近40%,市值超70億美元
極氪(ZK.US)美國IPO首日開盤報26美元,一度升39.62%至29.32美元,市值一度升至71.5億美元。極氪IPO定價為21美元/ADS。作為吉利控股集團旗下的豪華智能純電品牌,極氪刷新了新能源車企史上最快上市紀錄,從2021年4月15日品牌發佈到成功IPO僅37個月。2023年極氪實現營業收入517億元,整車毛利率達到15%。截至2024年4月底,已累計交付車輛超24萬台。今年1-4月,極氪實現了翻倍以上增長,同比大增111%,持續穩居20萬以上中國純電品牌銷量冠軍。作為最具全球價值的中國新能源題材,極氪此次成功在美上市,將有助於資本市場重估中國新能源汽車全球價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.